These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3206835)

  • 1. [Use of thymalin in stimulating an immune response in subjects inoculated with influenza vaccine].
    Degtiarev AA; Furgal SM; Zakharov VE
    Voen Med Zh; 1988 Sep; (9):37-8. PubMed ID: 3206835
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of thymalin in preventing respiratory infections].
    Degtiarev AA; Furgal SM
    Voen Med Zh; 1988 Jan; (1):47-8. PubMed ID: 3363889
    [No Abstract]   [Full Text] [Related]  

  • 3. [Properties and biological activity of inactivated influenza vaccine].
    D'iachenko AP
    Mikrobiol Zh (1978); 1982; 44(3):57-9. PubMed ID: 7121321
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of vaccination against influenza A in troop collectives].
    Khokhlov DT; Degtiarev AA; Furgal SM
    Voen Med Zh; 1987 Dec; (12):38-9. PubMed ID: 3441998
    [No Abstract]   [Full Text] [Related]  

  • 5. [Correlations between serum and secretory antibodies in persons inoculated with chromatographic influenza vaccine].
    Bichurina MA; Polzik TP; Mikhaĭlova GN; Ishkil'din MI
    Tr Inst Im Pastera; 1979; 52():75-82. PubMed ID: 550549
    [No Abstract]   [Full Text] [Related]  

  • 6. [Patterns of change in the immunity of those inoculated with an inactivated chromatographic influenza vaccine on an annual basis].
    Mukhina LP; Bichurina MA; Rozaeva NR
    Tr Inst Im Pastera; 1983; 61():151-5. PubMed ID: 6678508
    [No Abstract]   [Full Text] [Related]  

  • 7. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S; Süss J; Oehring H; Schmidt J
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human cytotoxic T cell response to influenza A vaccination.
    McMichael AJ; Gotch F; Cullen P; Askonas B; Webster RG
    Clin Exp Immunol; 1981 Feb; 43(2):276-84. PubMed ID: 6974066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of inactivated vaccines against influenza].
    Peradze TV; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Sep; (9):28-34. PubMed ID: 6755982
    [No Abstract]   [Full Text] [Related]  

  • 11. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of the immune response to influenza vaccine by acetylsalicylic acid: a clinical trial in a geriatric population.
    Hsia J; Tang T; Parrott M; Rogalla K
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):677-83. PubMed ID: 7746030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

  • 15. [Live influenza vaccine].
    Smorodintsev AA
    Vestn Akad Med Nauk SSSR; 1983; (12):15-21. PubMed ID: 6666315
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity.
    Chen D; Burger M; Chu Q; Endres R; Zuleger C; Dean H; Payne LG
    Virus Res; 2004 Jul; 103(1-2):147-53. PubMed ID: 15163503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of antineuraminidase antibodies in the human immunological response to the administration of live type A influenza vaccines].
    Naĭkhin AN; Topuriia NV; Denisov GM
    Mikrobiol Zh (1978); 1980; 42(5):642-5. PubMed ID: 7432210
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.
    Cox RJ; Madhun AS; Hauge S; Sjursen H; Major D; Kuhne M; Höschler K; Saville M; Vogel FR; Barclay W; Donatelli I; Zambon M; Wood J; Haaheim LR
    Vaccine; 2009 Mar; 27(13):1889-97. PubMed ID: 19368768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of one- and two-dose regimens of influenza vaccine for elderly men.
    Levine M; Beattie BL; McLean DM
    CMAJ; 1987 Oct; 137(8):722-6. PubMed ID: 3651943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.